Biologic agents and small-molecule inhibitors in systemic autoimmune conditions: An update
This review provides an updated overview of the mechanisms of action, therapeutic indications, efficacy, and safety of the currently available biologic disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs (tsDMARDs), based on the results of randomized clinical trials and real-world studies.